Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Shares Issued (2021 - 2024)

Pharma-Bio Serv filings provide 5 years of Shares Issued readings, the most recent being $1.0 for Q1 2024.

  • On a quarterly basis, Shares Issued changed N/A to $1.0 in Q1 2024 year-over-year; TTM through Apr 2024 was $6.0, a 25.0% decrease, with the full-year FY2023 number at $5.0, up 66.67% from a year prior.
  • Shares Issued hit $1.0 in Q1 2024 for Pharma-Bio Serv, down from $5.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $5.0 in Q2 2023 to a low of $1.0 in Q1 2024.
  • Median Shares Issued over the past 4 years was $2.5 (2021), compared with a mean of $2.75.
  • The widest YoY moves for Shares Issued: up 50.0% in 2022, down 50.0% in 2022.
  • Pharma-Bio Serv's Shares Issued stood at $2.0 in 2021, then soared by 50.0% to $3.0 in 2022, then surged by 66.67% to $5.0 in 2023, then crashed by 80.0% to $1.0 in 2024.
  • The last three reported values for Shares Issued were $1.0 (Q1 2024), $5.0 (Q2 2023), and $3.0 (Q1 2022) per Business Quant data.